In conclusion, targeting the SPOP/OTUD7A-EWS-FLI1 axis offers a promising therapeutic strategy for Ewing sarcoma, particularly in cases driven by the EWS-FLI1 fusion protein. This evidence concerns the gene FLI1 and Ewing sarcoma.